* Cross Country Healthcare Inc CCRN.OQ CCRN.O is
expected
to show a fall in quarterly revenue when it reports results on
May 3.
* The Boca Raton Florida-based company is expected to
report a
24.6% decrease in revenue to $594.999 million from $788.73
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on
February 22 2023, for the period ended March 31, was for revenue
between 590.00 million and 600.00 million.
* Refinitiv's mean analyst estimate for Cross Country
Healthcare
Inc is for earnings of 75 cents per share. The company's EPS
guidance on February 22 2023, for the period ended March 31, was
between 0.70 and 0.80
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cross
Country
Healthcare Inc is $38, above its last closing price of $22.45.
The company's guidance on February 22 2023 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between 590 million and 48 million.The
company's guidance on February 22 2023 for the period ended
March 31 was for gross profit margin between 21.5% and 22%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.89 0.89 1.09 Beat 21.9
Sep. 30 2022 0.96 0.95 1.07 Beat 12.6
Jun. 30 2022 1.35 1.35 1.40 Beat 3.8
Mar. 31 2022 1.34 1.31 1.70 Beat 29.3
Dec. 1.30 1.24 1.40 Beat 12.6
31 2021
Sep. 30 2021 0.34 0.34 0.61 Beat 77
Jun. 30 2021 0.40 0.40 0.47 Beat 18.7
Mar. 31 2021 0.34 0.34 0.58 Beat 69.9
This summary was machine generated May 2 at 02:06 GMT. All
figures in US dollars unless otherwise stated